BREAKTHROUGH: The US Food and Drug Administration (FDA) has granted a “Breakthrough Therapy” designation for donanemab, a potential new treatment for people with early symptomatic
BREAKTHROUGH & TREATMENT: The new Alzheimer’s drug aducanumabab (Aduhelm) has received accelerated approval by the US Food and Drug Administration. Why did it take so
RESEARCH: Scientists are using gold nanoparticles to create new images of the amyloid fibrils associated with Alzheimer’s disease and other neurodegenerative disorders. The fibrils are
THE CORONA VIRUS: Around the world, dementia researchers are studying SARS-CoV-2 virus’ (the cause of COVID-19) long-term effects on the brain and nervous system. It
ALZFORUM: Last year, people with dementia were most vulnerable, and this constrained research. Investigators adjusted and managed to make strides in important areas, from plasma
Researchers found FDA-approved Rolipram promotes the removal of abnormal tau proteins, improving memory. This could be big news for tau-based brain diseases such as Alzheimer’s,
DIET NEWS: Researchers find that certain people who produce equol — a substance created by gut bacteria after soy products are digested — display lower
Researchers at the University of Copenhagen have found certain types of physical activity are better than others in preventing dementia and disease. Find out more.
Researchers at Monash University are exploring the implications of treating obstructive sleep apnea to reduce the risk of dementia. This comes after finding a link
Researchers studying Australians with type 2 diabetes found those taking the first-line treatment medication metformin had significantly slower cognitive decline compared to those who did
Empower yourself with a detailed report of your brain’s function, consisting of an assessment of your cognitive function and your brain connectivity with a quick 45-minute on-site appointment.
Kimberly Warnick, Certified Dementia Practitioner and Care Navigator
Selling Alzheimer’s books takes time – buyers rarely commit right away. Smart authors plan for the long game, offering gentle, repeated reminders to buy. No tool does this more effectively or simply than the Alzheimer’s & Dementia Weekly Newsletter service. Keep your book—and its message—at the center of your readers’ attention.
What are the early symptoms of Alzheimer’s? When to get a professional evaluation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
No spam, only news and updates.
